Vessix Vascular, Inc.’s breakthrough device, an easy-to-use renal denervation system that treats uncontrolled hypertension, made it a natural acquisition target for Boston Scientific Corp. (NYSE: BSX). Boston Scientific develops and manufactures minimally invasive...
Slowing Down: Just 31 Buyers Spent $82.6 Billion The U.S. economy is still sluggish, and that seems to be the case in the health care M&A market in 2012. The number of billion-dollar deals announced by early December was off by 9% compared with 2011, and the...
Will The Big Deals Become A Thing Of The Past? With all the talk of health care reform, or “ObamaCare,” moving forward as a result of both the Supreme Court decision last June and President Obama’s reelection last month, we thought it might be worthwhile to take a...
Is your board good, or is it lucky? Increased litigation against senior living providers and senior care facilities poses a financial risk to those organizations and, in certain cases, may expose board members to claims of personal liability. What...
In Round 2, The Bankers Try Again To Get A Deal Done We have all heard about the gift that keeps on giving, and since we are in the Holiday Season with a lot of gift-giving going on, it just seemed to be an appropriate analogy. A few years ago, it was the slow...
Sailing Into the Sunset, But on Better Financial Footing Another chapter in the history of the skilled nursing business came to a close at the end of November, as privately-owned Genesis Healthcare completed its purchase of Sun Healthcare Group (formerly, NASDAQ:...